Glaxo Wellcome Manufacturing Pte Ltd. - B0033
Plant certified by the Brazilian health regulator (ANVISA)
ANVISA, the Brazilian health regulator, holds a valid Good Manufacturing Practice certificate for this plant, covering active pharmaceutical ingredients, valid until 2028-07-22. The certificate is issued after an inspection of the plant itself, which is why a foreign regulator names this site: goods made here are allowed on the Brazilian market. Process number 25351611941201771.
- Type
- Manufacturer
- Location
- Singapore
- Categories
- 医薬品製造
- Markets
- シンガポール, ブラジル
Listed in a source registry
Verified facts
- gmp-certified (green), checked 2026-08-21 ANVISA (Brazilian Health Regulatory Agency), public register of Good Manufacturing Practice certificates (CBPF)
- sanctions-clear (green), checked 2026-08-24 OpenSanctions
- debarment-clear (green), checked 2026-08-24 OpenSanctions
Import rules for these goods
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)